July 01, 2016
Bulletin interne de l'Institut Pasteur
News - July 1, 2016
- National Institutes of Health (NIH) / Biological Comparisons in Patient-Derived Models of Cancer (U01)
Purpose: to encourage applications wherein similarities and differences in the underlying biological mechanisms that drive cancer phenotype and response to perturbations between two or more patient-derived models of cancer originating from a common patient sample are delineated and compared.
Budget and duration: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The maximum project period is five years.
To find out more
Deadline: 14/08/2016 (letter of intent)
- Institut de Recherche en Santé Publique (IReSP) / Caisse Nationale de Solidarité pour l'Autonomie (CNSA) / Appel à projets 2016 Autisme - session 3
Objet: poursuivre les objectifs fixés dans les premières sessions du Plan Autisme afin d'encourager le développement de la recherche en sciences humaines et sociales spécifiquement consacrée aux troubles du spectre de l’autisme (TSA). Le présent appel s’articule autour de deux grands axes thématiques: (i) les parcours des personnes avec troubles du spectre de l’autisme; et (ii) l’accompagnement des proches aidants dans le parcours de l’enfant ou de l’adulte présentant un TSA.
Financement: 5 modalités de soutien:
- de 15 000€ à 50 000€ maximum pour les projets de la modalité «contrat de définition» (durée 12 mois maximum)
- de 15 000€ à 50 000€ maximum pour les projets de la modalité «aide à la mise en place de projets européens» (durée: 12 mois maximum)
- de 15 000€ à 50 000€ maximum pour les projets de la modalité «soutien à des réseaux de recherche» (durée: 12 mois maximum),
- de 50 000€ à 150 000€ maximum pour les projets de la modalité «soutien de projets de recherche» (durée: 36 mois maximum),
- de 50 000€ à 150 000€ maximum pour les projets de la modalité «soutien de projets de recherche exploitant des bases de données existantes» (durée: 36 mois maximum).
- Le montant minimum demandé par équipe bénéficiaire devra être de 10 000€.
En savoir plus
Date limite: 15/09/2016
- National Institutes of Health (NIH) / Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01)
Purpose: invites applications for human studies to elucidate the etiology and pathogenesis of the increased risk for neurocognitive impairment associated with type 2 diabetes.
Budget and duration: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates: February 5, June 5, October 5
To find out more
Deadline: 05/10/2016
- National Institutes of Health (NIH) / Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3)
Purpose: to elucidate the etiology and pathogenesis of the neurocognitive impairment in type 1 diabetes (T1D) with the ultimate goal of informing future strategies to mitigate this risk. Applications may propose de novo human studies or expansions of ongoing studies of well characterized T1D cohorts. Such expansions might include the addition of comprehensive neurocognitive measures (e.g., cognitive testing, neuroimaging, and biomarkers), clinical measures (e.g., glycemic control, frequency and severity of hypoglycemic episodes), including the use of continuous glucose monitoring (CGM) technologies and/or collection of data on other risk factors (e.g., micro- and macro-vascular disease, depression). It must be clearly explained how the collection of additional data will contribute to elucidation of the basis of neurocognitive sequelae of T1D. The focus of the research should be on the neurocognitive complications of T1D with a special emphasis on the contribution of glycemic dysregulation to neurocognitive complications associated with T1D.
Budget and duration: The maximum direct costs are $3 million for the entire project period and should reflect actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
To find out more
Deadline: 14/11/2016 (5:00 PM local time of applicant organization)